CARDIAC DRUG THERAPY - PART 4 pps
CARDIAC DRUG THERAPY - PART 4 pps
... hypertension. Am
J Med. 20 04; 116 :46 0 46 5.
53. Khan M Gabriel. Alpha-1 adrenergic blockers. In: Cardiac Drug Therapy, 4th ed. Philadelphia, WB
Saunders, 1995, p. 103.
54. INSIGHT: Brown MJ, Palmer ... renin-angiotensin system? J Am Coll Cardiol
2007 ;49 :11 64 1165.
Oh Byung-Hee, Mitchell J, Herron JR, et al. Aliskiren, an oral renin inhibitor, provides dose-dependent effi-
cacy and...
CARDIAC DRUG THERAPY - PART 8 ppsx
... Cardiology. Philadelphia, Saunders-Elsevier, 2006, p. 44 1.
326 Cardiac Drug Therapy
Alternatively, if drug therapy with a potent CYP -4 5 0 inhibitor is inevitable, choos-
ing a statin without relevant ... Study (42 ) randomly assigned 40 80 asymptomatic men aged 40 –
55 yr to a group treated with gemfibrozil 600 mg twice daily and another group receiving
2 94 Cardiac Drug...
An Introduction to Molecular Medicine and Gene Therapy - part 4 ppsx
... Molecular Medicine and Gene Therapy. Edited by Thomas F. Kresina, PhD
Copyright © 2001 by Wiley-Liss, Inc.
ISBNs: 0 -4 7 1-3 918 8-3 (Hardback); 0 -4 7 1-2 238 7-5 (Electronic)
148 GENE THERAPY FOR HEMATOLOGICAL ... Introduction to Molecular Medicine and Gene Therapy. Edited by Thomas F. Kresina, PhD
Copyright © 2001 by Wiley-Liss, Inc.
ISBNs: 0 -4 7 1-3 918 8-3 (Hardback)...
Managing Failed Anti-Reflux Therapy - part 4 ppsx
... Surgery.16th ed.20 04: 755–768,Copyright
20 04, with permission from Elsevier.)
54
MANAGING FAILED ANTI-REFLUX THERAPY
References
1. Shaheen N, Provenzale D. The epidemiology of gastroe-
sophagealreflux ... 2003;
70(5):S4–S19.
18. Pace F, Porro GB. Gastroesophageal reflux disease: a
typical spectrum of disease (a new conceptual frame-
work is not needed). Am J Gastroenterol 20 04; 99(5):
9...
CARDIAC DRUG THERAPY - PART 1 ppt
... [97 8-1 -5 882 9-9 0 4- 8 • 1-5 882 9-9 0 4- X/07 $30.00].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1
eISBN 1-5 9 74 5-2 3 8-6 ISBN13 97 8-1 -5 882 9-9 0 4- 8
Library of Congress Cataloging-in-Publication ... Ontario, Canada
Contemporary Cardiology
™
CARDIAC DRUG THERAPY
SEVENTH EDITION
ISBN: 97 8-1 -5 882 9-9 0 4- 8
E-ISBN: 97 8-1...
CARDIAC DRUG THERAPY - PART 2 docx
... Prevention of high-dose chemotherapy–induced cardiotoxicity
in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 2006;1 14: 247 4– 248 1.
62 Cardiac Drug Therapy
Chapter 3 ... in RCTs with follow-up beyond 5 yr.
In ASCOT-BPLA (16), baseline glucose concentration for amlodipine and the ateno-
lol-based regimen was 6. 24 versus 6 .4 mmol/L. At follow-up 5 yr la...
CARDIAC DRUG THERAPY - PART 3 docx
... advisable therapy
Beta-blocker FDA Second-line Advisable Advisable First-line First-line First-line First-line First-line
approved
a
therapy if not if not therapy therapy therapy therapy therapy
prone ... Publication No. 0 3-5 233, May 2003).
100 Cardiac Drug Theapy
3. Yeung Laiwah AC, Mactier RA. Antagonistic effect of non-steroidal anti-inflammatory drugs on fruse-
mide-indu...
CARDIAC DRUG THERAPY - PART 5 potx
... 35
6.0 14 16 18 20 22 23 25 27 29 31 32 34 36 38
7.0 17 19 21 23 25 27 29 32 34 36 38 40 42 44
8.0 19 22 14 26 29 31 34 36 38 41 43 46 48 50
9.0 22 24 27 30 32 35 38 41 43 46 49 51 54 57
10.0 24 27 ... 14 17 20 24 27 30 34
5.0 15 19 23 26 30 34 38
6.0 18 23 27 32 36 41 45
7.0 21 26 32 37 42 47 53
8.0 24 30 36 42 48 54 60
9.0 27 34 41 47 54 61 68
10.0 30 38...
CARDIAC DRUG THERAPY - PART 6 docx
... Jublin-Dannfelt A, Dahlquist R. Renal function and digoxin clearance during
quinidine therapy. Clin Physiol 1982;2 :40 1.
47 . Zatuchni J. Verapamil-digoxin interaction. Am Heart J 19 84; 108 :41 2.
48 . ... versus 347 (27.3%) in the
placebo group, a nonclinically significant reduction of 12.5%.
Chapter 14 / Management of Cardiac Arrhythmias 249
249
From: Contemporary Cardiology: Ca...
CARDIAC DRUG THERAPY - PART 7 pot
... beta-blockers or disopyramide.
276 Cardiac Drug Therapy
Drug name: Sotalol
Trade names: Betapace, Sotacor, Beta-Cardone (UK)
Supplied: 40 , 80, 160 mg
Dosage: 40 –80 mg once or twice daily; max. 240 ... study in predicting drug effi-
cacy. Am J Cardiol 19 84; 54: 40D.
49 . Chilson DA, Heger JJ, Zipes DP, et al. Electrophysiologic effects and clinical efficacy of oral propa-
fenon...